Search Results - Perrot, Aurore
- Showing 1 - 20 results of 31
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Lactic acidosis and hypoglycemia as markers of disease progression of multiple myeloma: A case report by Ziegler, Caroline, Volkov, Lev, Marnai, Rémy, Courte, Guilhem, Cravoisy, Aurélie, Conrad, Marie, Nace, Lionel, Melone, Agnès, Perrot, Aurore, Gibot, Sébastien
Published 2021Text -
7
-
8
Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30(+) Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient... by Perrot, Aurore, Monjanel, Hélène, Bouabdallah, Réda, Quittet, Philippe, Sarkozy, Clémentine, Bernard, Marc, Stamatoullas, Aspasia, Borel, Cécile, Bouabdallah, Krimo, Nicolas-Virelizier, Emmanuelle, Fournier, Marion, Morschhauser, Franck, Brice, Pauline
Published 2016Text -
9
A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia by Perrot, Aurore, Pionneau, Cédric, Nadaud, Sophie, Davi, Frédéric, Leblond, Véronique, Jacob, Frédéric, Merle-Béral, Hélène, Herbrecht, Raoul, Béné, Marie-Christine, Gribben, John G., Bahram, Seiamak, Vallat, Laurent
Published 2011Text -
10
Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow by Mazzotti, Céline, Buisson, Laure, Maheo, Sabrina, Perrot, Aurore, Chretien, Marie-Lorraine, Leleu, Xavier, Hulin, Cyrille, Manier, Salomon, Hébraud, Benjamin, Roussel, Murielle, Do Souto, Laura, Attal, Michel, Avet-Loiseau, Hervé, Corre, Jill
Published 2018Text -
11
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia by Tomowiak, Cécile, Poulain, Stéphanie, Herbaux, Charles, Perrot, Aurore, Mahé, Béatrice, Morel, Pierre, Aurran, Thérèse, Tournilhac, Olivier, Leprêtre, Stéphane, Assaad, Souad, Villemagne, Bruno, Casasnovas, Olivier, Nollet, Delphine, Roos-Weil, Damien, Chevret, Sylvie, Leblond, Véronique
Published 2021Text -
12
Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT by Rossi, Cédric, Mounier, Morgane, Brice, Pauline, Safar, Violaine, Nicolas-Virelizier, Emmanuelle, Rey, Philippe, Stamatoullas-Bastard, Aspasia, Alcantara, Marion, Chauchet, Adrien, Reboursière, Emilie, Filliatre, Lauriane, Perrot, Aurore, Garciaz, Sylvain, Salles, Gilles, Coiffier, Bertrand, Ghesquières, Hervé, Casasnovas, René-Olivier
Published 2017Text -
13
All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-0... by Touzeau, Cyrille, Perrot, Aurore, Roussel, Murielle, Karlin, Lionel, Benboubker, Lotfi, Jacquet, Caroline, Mohty, Mohamad, Facon, Thierry, Manier, Salomon, Chretien, Marie-Lorraine, Tiab, Mourad, Hulin, Cyrille, Leleu, Xavier, Loiseau, Hervé Avet, Dejoie, Thomas, Planche, Lucie, Attal, Michel, Moreau, Philippe
Published 2022Text -
14
Subgroup analysis of ICARIA‐MM study in relapsed/refractory multiple myeloma patients with high‐risk cytogenetics by Harrison, Simon J., Perrot, Aurore, Alegre, Adrian, Simpson, David, Wang, Ming Chung, Spencer, Andrew, Delimpasi, Sosana, Hulin, Cyrille, Sunami, Kazutaka, Facon, Thierry, Vlummens, Philip, Yong, Kwee, Campana, Frank, Inchauspé, Marlène, Macé, Sandrine, Risse, Marie‐Laure, van de Velde, Helgi, Richardson, Paul
Published 2021Text -
15
Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies by Cabannes‐Hamy, Aurélie, Peyrade, Frederic, Jardin, Fabrice, Emile, Jean‐François, Delwail, Vincent, Mounier, Nicolas, Haioun, Corinne, Perrot, Aurore, Fitoussi, Olivier, Lara, Diane, Delarue, Richard, André, Marc, Offner, Fritz, Ghesquières, Hervé, Pascal, Laurent, Soussain, Carole, Lazarovici, Julien, Schiano, Jean‐Marc, Gaulard, Philippe, Tilly, Hervé, Thieblemont, Catherine
Published 2018Text -
16
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab by Mikhael, Joseph, Belhadj-Merzoug, Karim, Hulin, Cyrille, Vincent, Laure, Moreau, Philippe, Gasparetto, Cristina, Pour, Ludek, Spicka, Ivan, Vij, Ravi, Zonder, Jeffrey, Atanackovic, Djordje, Gabrail, Nashat, Martin, Thomas G., Perrot, Aurore, Bensfia, Samira, Weng, Qilong, Brillac, Claire, Semiond, Dorothée, Macé, Sandrine, Corzo, Kathryn P., Leleu, Xavier
Published 2021Text -
17
A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts by Ghesquières, Hervé, Larrabee, Beth R., Casasnovas, Olivier, Maurer, Matthew J., McKay, James D., Ansell, Stephen M., Montgomery, Dorothy, Asmann, Yan W., Farrell, Katrina, Verney, Aurélie, Slager, Susan L., Allmer, Cristine, Perrot, Aurore, Delarue, Richard, Habermann, Thomas M., Dupuis, Jehan, Link, Brian K., Canioni, Danielle, Dogan, Ahmet, Cozen, Wendy, Jarrett, Ruth F., Cerhan, James R., Salles, Gilles
Published 2016Text -
18
del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma by Corre, Jill, Perrot, Aurore, Caillot, Denis, Belhadj, Karim, Hulin, Cyrille, Leleu, Xavier, Mohty, Mohamad, Facon, Thierry, Buisson, Laure, Do Souto, Laura, Lannes, Romain, Dufrechou, Stephanie, Prade, Naïs, Orsini-Piocelle, Frederique, Voillat, Laurent, Jaccard, Arnaud, Karlin, Lionel, Macro, Margaret, Brechignac, Sabine, Dib, Mamoun, Sanhes, Laurence, Fontan, Jean, Clement-Filliatre, Lauriane, Marolleau, Jean-Pierre, Minvielle, Stephane, Moreau, Philippe, Avet-Loiseau, Hervé
Published 2021Text -
19
Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial by Perrot, Aurore, Facon, Thierry, Plesner, Torben, Usmani, Saad Z., Kumar, Shaji, Bahlis, Nizar J., Hulin, Cyrille, Orlowski, Robert Z., Nahi, Hareth, Mollee, Peter, Ramasamy, Karthik, Roussel, Murielle, Jaccard, Arnaud, Delforge, Michel, Karlin, Lionel, Arnulf, Bertrand, Chari, Ajai, He, Jianming, Ho, Kai Fai, Van Rampelbergh, Rian, Uhlar, Clarissa M., Wang, Jianping, Kobos, Rachel, Gries, Katharine S., Fastenau, John, Weisel, Katja
Published 2021Text -
20
A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial by Dumontet, Charles, Hulin, Cyrille, Dimopoulos, Meletios A., Belch, Andrew, Dispenzieri, Angela, Ludwig, Heinz, Rodon, Philippe, Van Droogenbroeck, Jan, Qiu, Lugui, Cavo, Michele, Van de Velde, Ann, Lahuerta, Juan José, Allangba, Olivier, Lee, Jae Hoon, Boyle, Eileen, Perrot, Aurore, Moreau, Philippe, Manier, Salomon, Attal, Michel, Roussel, Murielle, Mohty, Mohamad, Mary, Jean Yves, Civet, Alexandre, Costa, Bruno, Tinel, Antoine, Gaston-Mathé, Yann, Facon, Thierry
Published 2018Text